Congenital Myasthenia Syndromes Panel
New York
Approved
Genes
Conditions
- Myasthenia/Myasthenic Syndromes (Congenital)
Clinical Utility
- Molecular confirmation of a clinical diagnosis.
- To assist with decisions regarding treatment and management of individuals with congenital myasthenia.
- Testing of at-risk relatives for specific known pathogenic variant(s) previously identified in an affected family member.
Lab Method
- Next-Gen Sequencing
- Deletion/Duplication Analysis
Test Code
945
CPT Codes*
81406x1, 81479x1
ABN Required
No
Turnaround Time**
4 weeks
Preferred Specimen
Alternative Specimen
*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
**Turnaround times are estimates and begin once the sample(s) begin processing at the GeneDx lab and could be extended in situations outside GeneDx’s control.
Test Documents
Billing
Targeted Variant Testing